Abiopharma

🔍 Swinbank Joe B (Executive)

Company: PROSPERITY BANCSHARES INC (PB)

Report Date: 2026-07-01

Detailed Transactions and Holdings:

• Acquired 64,877 shares of Common Stock (Direct)
  Date: 2026-07-01 | Code: A | equity_swap_involved: false | shares_owned_after: 64,877.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 23,241 shares of Common Stock (Direct)
  Date: 2026-07-01 | Code: A | equity_swap_involved: false | shares_owned_after: 23,241.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 38,638 shares of Common Stock (Direct)
  Date: 2026-07-01 | Code: A | equity_swap_involved: false | shares_owned_after: 38,638.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Acquired in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 27, 2026, by and between Prosperity Bancshares, Inc., a Texas corporation ("Prosperity") and Stellar Bancorp, Inc., a Texas corporation ("Stellar"). On July 1, 2026 (the "Effective Time"), upon and subject to the terms and conditions set forth in the merger agreement, (i) each share of Stellar's common stock, par value $0.01 per share, outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive (a) 0.3803 shares of common stock, par value $1.00 per share, of Prosperity and (b) an amount in cash equal to $11.36 ((a) and (b) together, the "Per Share Merger Consideration"), and (ii) each outstanding Stellar restricted stock award subject solely to service-based vesting, repurchase or other lapse restriction vested and was converted into the right to receive (without interest) the Per Share Merger Consideration.